Pharmacovigilance Conference London, England, UK 10-11 May 2017

Description:
Changes in pharmacovigilance activities in and outside Europe have prompted new challenges for all stakeholders. Methodologies used in risk management are evolving and becoming increasingly accurate in addressing potential and identified risks.

Join the Pharmacovigilance Conference to discuss paths forward and formulate answers to key questions:
1.Benefit-risk assessment - What and how to do in practice?
2.What are the key pharmacovigilance inspection trends, plus options for improving organisation and processes - including the role of the EU QPPV and the Pharmacovigilance System Master File (PSMF)?
3.What progress and insights have been made within new EU project WEB-RADR on pharmacovigilance and social media?
4.What are the current regulatory and practical challenges of the Risk Management Plan and can potential improvements be identified?
5.How do the latest Pharmacoepidemiological approaches support risk management?

The conference format is designed to generate dialogue and solutions through a series of interactive sessions. Discussion content will be tailored on the basis of questions raised in advance by attendees.

Prices:
Industry Member Early-Bird: EUR 1230,
Industry Member: EUR 1430,
Industry Non-Member: EUR 1585,
Government/Charitable/Non-profit/Academia (Full-Time) Member: EUR 715,
Government/Charitable/Non-profit/Academia (Full-Time) Non-Member: EUR 870